165 related articles for article (PubMed ID: 25232062)
21. The forkhead transcription factor FOXP1 represses human plasma cell differentiation.
van Keimpema M; Grüneberg LJ; Mokry M; van Boxtel R; van Zelm MC; Coffer P; Pals ST; Spaargaren M
Blood; 2015 Oct; 126(18):2098-109. PubMed ID: 26289642
[TBL] [Abstract][Full Text] [Related]
22. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
[TBL] [Abstract][Full Text] [Related]
23. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.
Audard V; Zhang SY; Copie-Bergman C; Rucker-Martin C; Ory V; Candelier M; Baia M; Lang P; Pawlak A; Sahali D
Blood; 2010 May; 115(18):3756-62. PubMed ID: 20200355
[TBL] [Abstract][Full Text] [Related]
24. A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells.
Zahn M; Marienfeld R; Melzner I; Heinrich J; Renner B; Wegener S; Mießner A; Barth TF; Dorsch K; Brüderlein S; Möller P
Blood; 2017 Mar; 129(11):1480-1490. PubMed ID: 28082443
[TBL] [Abstract][Full Text] [Related]
25. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
[TBL] [Abstract][Full Text] [Related]
28. BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed-Sternberg cells.
Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
[TBL] [Abstract][Full Text] [Related]
29. FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
Xie L; Ritz O; Leithäuser F; Guan H; Färbinger J; Weitzer CD; Gehringer F; Bruederlein S; Holzmann K; Vogel MJ; Möller P; Wirth T; Ushmorov A
Oncotarget; 2014 Jul; 5(14):5392-402. PubMed ID: 24977668
[TBL] [Abstract][Full Text] [Related]
30. Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation.
Seitz V; Thomas PE; Zimmermann K; Paul U; Ehlers A; Joosten M; Dimitrova L; Lenze D; Sommerfeld A; Oker E; Leser U; Stein H; Hummel M
Haematologica; 2011 Jun; 96(6):863-70. PubMed ID: 21393330
[TBL] [Abstract][Full Text] [Related]
31. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
[TBL] [Abstract][Full Text] [Related]
32. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma.
Leventaki V; Drakos E; Karanikou M; Psatha K; Lin P; Schlette E; Eliopoulos A; Vassilakopoulos TP; Papadaki H; Patsouris E; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2014 Mar; 45(3):565-72. PubMed ID: 24457077
[TBL] [Abstract][Full Text] [Related]
33. Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.
Guan H; Xie L; Wirth T; Ushmorov A
Oncotarget; 2016 Jun; 7(24):36854-36864. PubMed ID: 27166193
[TBL] [Abstract][Full Text] [Related]
34. PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
Yuki H; Ueno S; Tatetsu H; Niiro H; Iino T; Endo S; Kawano Y; Komohara Y; Takeya M; Hata H; Okada S; Watanabe T; Akashi K; Mitsuya H; Okuno Y
Blood; 2013 Feb; 121(6):962-70. PubMed ID: 23212521
[TBL] [Abstract][Full Text] [Related]
35. Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
Rengstl B; Kim S; Döring C; Weiser C; Bein J; Bankov K; Herling M; Newrzela S; Hansmann ML; Hartmann S
PLoS One; 2017; 12(5):e0177378. PubMed ID: 28505189
[TBL] [Abstract][Full Text] [Related]
36. Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
von Hoff L; Kärgel E; Franke V; McShane E; Schulz-Beiss KW; Patone G; Schleussner N; Kolesnichenko M; Hübner N; Daumke O; Selbach M; Akalin A; Mathas S; Scheidereit C
Blood; 2019 Mar; 133(13):1489-1494. PubMed ID: 30696620
[TBL] [Abstract][Full Text] [Related]
37. Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker.
Siref A; McCormack C; Huang Q; Lim W; Alkan S
Leuk Res; 2020 Sep; 96():106408. PubMed ID: 32659407
[TBL] [Abstract][Full Text] [Related]
38. Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma.
Vera-Lozada G; Segges P; Stefanoff CG; Barros MHM; Niedobitek G; Hassan R
Hematol Oncol; 2018 Oct; 36(4):663-670. PubMed ID: 29901224
[TBL] [Abstract][Full Text] [Related]
39. FOXO in B-cell lymphopoiesis and B cell neoplasia.
Ushmorov A; Wirth T
Semin Cancer Biol; 2018 Jun; 50():132-141. PubMed ID: 28774833
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma.
Schmitz R; Stanelle J; Hansmann ML; Küppers R
Annu Rev Pathol; 2009; 4():151-74. PubMed ID: 19400691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
